2019 China Focus@BIO Philadelphia successfully ended, leading a new model of cross-border healthcare cooperation.

The conference organized on June 2 attracted numerous Chinese and American pharmaceutical companies, investment institutions and other well-known consulting institutions attended.

During the conference,  panelists discussed cross-border Investment and collaborations in biotech and pharma along with artificial intelligence and digital health. In terms of 1-on-1 meetings, both the capital and project parties have achieved fruitful results. In addition, participant enterprises have carried out comprehensive exhibitions of their products and services.

Three finalists were selected in the Mybiogate Global Healthcare Innovation Competition that was held in conjunction with the conference.